Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Baxter
AstraZeneca
Cipla
Daiichi Sankyo
UBS
Novartis
Boehringer Ingelheim
Cantor Fitzgerald

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Tablet composition
Abstract:A tablet composition containing N-(trans-4-isopropylcydohexanecarbonyl)-D-phenylalanine and low substituted hydroxypropylcellulose is disclosed. This tablet composition is rapidly disintegrated in the stomach after the administration and absorbed without being influenced by meals to inhibit the rise of the blood sugar levels of diabetics after meals.
Inventor(s): Yabuki; Akira (Kawasaki, JP), Kaida; Masato (Kawasaki, JP), Ando; Takahiko (Kawasaki, JP), Ninomiya; Nobutaka (Kawasaki, JP), Ozaki; Masanao (Kawasaki, JP)
Assignee: Ajinomoto Co., Inc. (Tokyo, JP)
Filing Date:May 14, 1999
Application Number:09/311,060
Claims:1. A tablet composition containing N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine and 5 to 50% by weight of low substituted hydroxypropylcellulose.

2. A tablet composition containing 5 to 50% by weight of N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine, 5 to 40% by weight of low substituted hydroxypropylcellulose having a hydroxypropyl group content of 5.0 to 16.0% by weight, 10 to 90% by weight of a filler and 0.1 to 5% by weight of hydroxypropyl cellulose having a hydroxypropyl group content of 53.4 to 77.5% by weight.

3. The tablet composition according to claim 1, which further contains a filler.

4. The tablet composition according to claim 3, wherein at least one kind of the filler is lactose.

5. The tablet composition according to claim 1, which further contains hydroxypropyl cellulose.

6. The tablet composition according to claim 5, wherein the hydroxypropyl cellulose contains 53.4 to 77.5% by weight of hydroxypropoxyl group.

7. A tablet composition containing 5 to 50% by weight of N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine, 5 to 40% by weight of low substituted hydroxypropylcellulose and 10 to 90% by weight of a filler.

8. The tablet composition according to claim 7, wherein the filler is lactose.

9. The tablet composition according to claim 7, which further contains hydroxypropyl cellulose.

10. The tablet composition according to claim 9, wherein the hydroxypropyl cellulose contains 53.4 to 77.5% by weight of hydroxypropoxyl group.

11. The tablet composition according to claim 2, wherein the filler is lactose.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
McKinsey
US Army
Argus Health
Moodys
Julphar
McKesson
UBS
Fish and Richardson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot